Cibus, Inc. (NASDAQ:CBUS), an agricultural technology company, has acknowledged the European Parliament's draft report on the proposal for regulation of plants obtained from New Genomic Techniques (NGTs). The proposal supports the introduction of a new regulation on plants obtained by NGTs and identifies a 'Conventional-like' category of NGT products. This would bring EU policy closer to that of trading partners in North and South America, Australia, and Japan. Products from Cibus' gene editing platform, such as disease-resistant canola and oilseed rape, would be considered 'Conventional-like'.